# Gazyva

NDC: 50242-070
Generic name: obinutuzumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20131101

FDA application: BLA125486

## Active ingredients

- OBINUTUZUMAB: 1000 mg/40mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda